Literature DB >> 15967554

Emotional exposure in the treatment of substance use disorders: conceptual model, evidence, and future directions.

Michael W Otto1, Mark B Powers, Diana Fischmann.   

Abstract

In this article, we review research on the nature and treatment of panic disorder, and apply these findings to a discussion of the role of internal cue exposure in the treatment of substance use disorders (SUDs). Two features of panic treatment were used as a model for interventions for SUDs: exposure to internal (interoceptive) cues rather than reliance on external (environmental) exposure alone, and use of cue exposure to try to inoculate individuals against future maladaptive patterns. Specifically, we emphasized the role of exposure to internal, largely emotional cues, as a way to enhance resilience to cues for relapse in individuals with SUDs. Hypothesized moderators and mediators of this treatment approach were discussed, as were similarities between this research agenda and an increasing focus on the role of emotional acceptance/tolerance in cognitive-behavioral treatments.

Entities:  

Mesh:

Year:  2005        PMID: 15967554     DOI: 10.1016/j.cpr.2005.05.002

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  12 in total

1.  A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence.

Authors:  Michael W Otto; Bridget A Hearon; R Kathryn McHugh; Amanda W Calkins; Elizabeth Pratt; Heather W Murray; Steven A Safren; Mark H Pollack
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

Review 2.  Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults.

Authors:  Teresa M Leyro; Michael J Zvolensky; Amit Bernstein
Journal:  Psychol Bull       Date:  2010-07       Impact factor: 17.737

3.  Emotion regulation and motives for illicit drug use in opioid-dependent patients.

Authors:  Alexandra K Gold; Georgia Stathopoulou; Michael W Otto
Journal:  Cogn Behav Ther       Date:  2019-02-14

4.  Initial RCT of a distress tolerance treatment for individuals with substance use disorders.

Authors:  Marina A Bornovalova; Kim L Gratz; Stacey B Daughters; Elizabeth D Hunt; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-10-07       Impact factor: 4.492

Review 5.  Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change.

Authors:  Katie Witkiewitz; Sarah Bowen; Erin N Harrop; Haley Douglas; Matthew Enkema; Carly Sedgwick
Journal:  Subst Use Misuse       Date:  2014-04       Impact factor: 2.164

6.  Self-reports of interoceptive responses during stress and drug cue-related experiences in cocaine- and alcohol-dependent individuals.

Authors:  Keri L Bergquist; Helen C Fox; Rajita Sinha
Journal:  Exp Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.157

7.  Shared Variance among Self-Report and Behavioral Measures of Distress Intolerance.

Authors:  R Kathryn McHugh; Stacey B Daughters; Carl W Lejuez; Heather W Murray; Bridget A Hearon; Stephanie M Gorka; Michael W Otto
Journal:  Cognit Ther Res       Date:  2011-06

8.  Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment.

Authors:  C W Lejuez; Michael J Zvolensky; Stacey B Daughters; Marina A Bornovalova; Autumn Paulson; Matthew T Tull; Kenneth Ettinger; Michael W Otto
Journal:  Behav Res Ther       Date:  2008-03-28

9.  A randomized clinical trial of a tailored behavioral smoking cessation preparation program.

Authors:  Danielle E McCarthy; Krysten W Bold; Haruka Minami; Vivian M Yeh
Journal:  Behav Res Ther       Date:  2015-12-15

10.  Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial.

Authors:  Sarah Bowen; Katie Witkiewitz; Seema L Clifasefi; Joel Grow; Neharika Chawla; Sharon H Hsu; Haley A Carroll; Erin Harrop; Susan E Collins; M Kathleen Lustyk; Mary E Larimer
Journal:  JAMA Psychiatry       Date:  2014-05       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.